StockNow
Log in
U.S. Markets

Novo Nordisk (NOVOB DC) sues Eli lilly (LLY) in US federal court, alleging claim under the Lanham Act, according to court records

StockNow breaking-news AI analysis

Novo Nordisk sued Eli Lilly over misleading ads as Lilly holds a ~60% US market share lead. Novo faces 2026 revenue pressure while transitioning to direct legal and marketing competition.

News detail

Is suing over misleading weight loss ads.

2 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

U.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)